t
Jorgen Kokke, Chief Executive Officer of Genus plc, exercised 7,649 nil-cost options on 13 May 2026, which had vested on 4 May 2026. On the same date, he sold 3,450 ordinary shares in Genus on the London Stock Exchange at 2,267.9397p per share to offset income tax and social security liabilities, retaining the remaining 4,199 ordinary shares.
| Date | 13 May 2026 |
| Time | 12:32:38 |
| Category | Director/PDMR dealings |
| ID | 2006E |
13 May 2026
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that further to the vesting on 4 May 2026 of 7,649 nil-cost options granted over ordinary shares on 2 May 2023 in respect of buyout of compensation forfeited from his previous employer, Jorgen Kokke, Chief Executive Officer, exercised 7,649 nil-cost options on 13 May 2026.
As listed in table A below, Jorgen Kokke sold 3,450 ordinary shares in Genus on 13 May 2026 on the London Stock Exchange to offset income tax and social security liabilities due on the exercise of those vested options and retained the balance of 4,199 ordinary shares.
The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of nil-cost options exercised and ordinary shares sold on 13 May 2026.
For further information please contact:
Genus:
Vaughn Walton, Deputy Company Secretary Tel: +44 (0)1256 347100
Table A - Exercise of buy-out awards vesting on 13 May 2026
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
||||||
|
a. |
Name |
Jorgen Kokke |
|||||
|
2. |
Reason for the notification |
||||||
|
a. |
Position/status |
Chief Executive |
|||||
|
b. |
Initial notification /Amendment |
Initial notification |
|||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
|
a. |
Name |
Genus plc |
|||||
|
b. |
LEI |
54930022EOITNKSIGH56 |
|||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
|
a. |
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each
GB0002074580 |
|||||
|
b. |
Nature of the transaction |
Exercise of nil-cost options granted on 2 May 2023 over ordinary shares in Genus in respect of buyout of compensation forfeited from his previous employer.
|
|||||
|
c. |
Price(s) and volume(s) |
|
|||||
|
d. |
Aggregated information · Aggregated volume · Price
|
|
|||||
|
e. |
Date of the transaction |
2026-05-13 |
|||||
|
f. |
Place of the transaction |
Outside a trading venue. |
|||||
|
5. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
|
a.
|
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each
GB0002074580 |
|||||
|
b. |
Nature of the transaction |
Sale of shares arising from the exercise of nil-cost options to offset income tax and social security liabilities due on the exercise. |
|||||
|
c. |
Price(s) and volume(s) |
|
|||||
|
d. |
Aggregated information · Aggregated volume · Price
|
|
|||||
|
e. |
Date of the transaction |
2026-05-13 |
|||||
|
f. |
Place of the transaction |
London Stock Exchange, Main Market (XLON)
|
|||||